https://www.selleckchem.com/products/tpca-1.html
(1) Aims Patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (T, usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and treatment decreases the risk of TB. This study evaluated the diagnostic performance of different LTBI screening strategies in patients with inflammatory bowel disease (IBD). (2) Methods Patients in the Spanish ENEIDA registry with IBD screened for LTBI between January 2003 and January 2018 were included. The diagnostic yield of different s
Like
Comment
Share
